CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Excimer Light Treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01956435
NCT01956435N/ACompleted
CompareCT.gov

Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study

Seton Healthcare Family·interventional·Posted Oct 8, 2013·Updated Dec 2, 2017

In Brief

A clinical study evaluating Excimer Light Treatment for Idiopathic Guttate Hypomelanosis. Completed, enrolled 6 participants across 1 site.

Detailed Summary

This pilot study will consist of 10 adult subjects with symmetric idiopathic guttate hypomelanosis on the lower legs. Subjects will be randomized to which extremity (right or left) will be treated. Treatments with the Xtrac Excimer laser will be performed twice weekly for 12 weeks using the typical vitiligo protocol. Our goal is to determine the effectiveness of excimer laser for repigmentation of idiopathic guttate hypomelanosis. Effectiveness will be graded by the blinded observer scale via photographic comparisons and will be graded by subject via survey every 4 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Guttate Hypomelanosis
CountriesUnited States
CollaboratorsAmerican Society of Dermatologic Surgeons, Photomedex

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 8, 2013
Enrollment StartMar 1, 2014
Primary CompletionJun 1, 2015
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.7 years ago

Interventions

Excimer Light Treatmentdevice

Excimer light treatment will be performed on one leg of every subject as the intervention while the subjects other leg will serve as a control